FR3040860B1 - Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique - Google Patents

Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique Download PDF

Info

Publication number
FR3040860B1
FR3040860B1 FR1558409A FR1558409A FR3040860B1 FR 3040860 B1 FR3040860 B1 FR 3040860B1 FR 1558409 A FR1558409 A FR 1558409A FR 1558409 A FR1558409 A FR 1558409A FR 3040860 B1 FR3040860 B1 FR 3040860B1
Authority
FR
France
Prior art keywords
storage
bone marrow
injectable
storage medium
peripheral blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1558409A
Other languages
English (en)
French (fr)
Other versions
FR3040860A1 (fr
Inventor
Zoran Ivanovic
Jean Chevaleyre
Laura Rodriguez
Esther Attebi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Bordeaux
Original Assignee
Centre National de la Recherche Scientifique CNRS
Etablissement Francais du Sang
Universite de Bordeaux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1558409A priority Critical patent/FR3040860B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Etablissement Francais du Sang, Universite de Bordeaux filed Critical Centre National de la Recherche Scientifique CNRS
Priority to HK18110115.9A priority patent/HK1250604B/xx
Priority to CN201680033782.6A priority patent/CN108135154B/zh
Priority to PCT/FR2016/052253 priority patent/WO2017042501A1/fr
Priority to CA2986267A priority patent/CA2986267A1/fr
Priority to EP16777718.4A priority patent/EP3346833B1/fr
Priority to RU2017142903A priority patent/RU2727643C2/ru
Priority to US15/580,699 priority patent/US11589575B2/en
Publication of FR3040860A1 publication Critical patent/FR3040860A1/fr
Application granted granted Critical
Publication of FR3040860B1 publication Critical patent/FR3040860B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
FR1558409A 2015-09-10 2015-09-10 Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique Active FR3040860B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR1558409A FR3040860B1 (fr) 2015-09-10 2015-09-10 Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
CN201680033782.6A CN108135154B (zh) 2015-09-10 2016-09-09 用于保存来自胎盘血、来自骨髓和来自外周血的细胞的可注射保存培养基
PCT/FR2016/052253 WO2017042501A1 (fr) 2015-09-10 2016-09-09 Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang périphérique
CA2986267A CA2986267A1 (fr) 2015-09-10 2016-09-09 Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
HK18110115.9A HK1250604B (en) 2015-09-10 2016-09-09 Use of injectable preserving medium for preserving cells from placental blood, from bone marrow and from peripheral blood
EP16777718.4A EP3346833B1 (fr) 2015-09-10 2016-09-09 Utilisation de milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang périphérique
RU2017142903A RU2727643C2 (ru) 2015-09-10 2016-09-09 Инъецируемая консервирующая среда для консервации клеток плацентарной крови, костного мозга и периферической крови
US15/580,699 US11589575B2 (en) 2015-09-10 2016-09-09 Injectable preserving medium for preserving cells from placental blood, from bone marrow and from peripheral blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1558409A FR3040860B1 (fr) 2015-09-10 2015-09-10 Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
FR1558409 2015-09-10

Publications (2)

Publication Number Publication Date
FR3040860A1 FR3040860A1 (fr) 2017-03-17
FR3040860B1 true FR3040860B1 (fr) 2020-05-15

Family

ID=55178079

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1558409A Active FR3040860B1 (fr) 2015-09-10 2015-09-10 Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique

Country Status (7)

Country Link
US (1) US11589575B2 (OSRAM)
EP (1) EP3346833B1 (OSRAM)
CN (1) CN108135154B (OSRAM)
CA (1) CA2986267A1 (OSRAM)
FR (1) FR3040860B1 (OSRAM)
RU (1) RU2727643C2 (OSRAM)
WO (1) WO2017042501A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
FR3088541B1 (fr) * 2018-11-15 2021-11-05 Lab Francais Du Fractionnement Procede de conservation de cellules a visee therapeutique
AU2020241910B2 (en) * 2019-03-15 2023-12-21 Megakaryon Corporation Storage liquid for mammalian cells
FR3101538B1 (fr) * 2019-10-07 2023-05-05 Action Vitale Composition de la solution physiologique contenant de l’eau de mer et de la glutamine et utilisable pour augmenter la viabilité fonctionnelle des tissus biologiques et des cellules vivantes.
JP7018527B1 (ja) 2020-12-16 2022-02-10 アニコム先進医療研究所株式会社 細胞の保存方法および細胞懸濁液

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543316A (en) * 1994-04-20 1996-08-06 Diacrin, Inc. Injectable culture medium for maintaining viability of myoblast cells
AU6486096A (en) * 1996-05-08 1997-11-26 Government Of The United States Of America As Represented By The Secretary Of The Army Pharmaceutical compositions containing alpha-keto carboxylates
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6153582A (en) * 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
GB0001172D0 (en) * 2000-01-20 2000-03-08 Res Del International Limited Physiological medium for perfusing, preserving and storing isolated cell tissue and organ samples
ATE330468T1 (de) * 2000-11-03 2006-07-15 Vitrolife Ab Lösung zur evaluierung und konservierung
US20050053912A1 (en) 2001-06-11 2005-03-10 Roth Mark B. Methods for inducing reversible stasis
RU2188654C1 (ru) 2001-12-13 2002-09-10 Государственное некоммерческое учреждение Гематологический научный центр РАМН Препараты крови для трансфузии и способ их получения
AU2003216286B2 (en) * 2002-02-13 2008-08-28 Celularity Inc. Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US8374794B1 (en) * 2003-06-02 2013-02-12 Rib-X Pharmaceuticals, Inc. Protein synthesis modulators
CN1772882A (zh) * 2004-10-12 2006-05-17 尼普洛株式会社 细胞保存液及其调制方法、细胞保存方法、细胞培养方法
US20100311035A1 (en) * 2005-05-26 2010-12-09 Arrington Ben O'mar Preservation solution for organs and biological tissues
DE102005049226B4 (de) * 2005-10-14 2007-08-02 Technische Universität München Probenahmesystem für fluide Proben
RU2311027C1 (ru) 2006-05-11 2007-11-27 Институт физиологии Коми научного центра Уральского отделения Российской Академии Наук Раствор для консервирования лейкоцитов при околонулевой температуре
US20080089947A1 (en) 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia
WO2008131973A2 (en) * 2007-04-26 2008-11-06 Medinnova As Transplant storage
ITUD20080058A1 (it) * 2008-03-18 2009-09-19 Thankstem S R L Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali
WO2010050073A1 (ja) 2008-10-31 2010-05-06 デンタルサポート株式会社 再生医療に利用する生体組織などの低酸素滅菌・保存・運搬・管理用システム
AU2010274993B2 (en) * 2009-07-20 2016-07-14 The General Hospital Corporation D/B/A Massachusetts General Hospital Methods and compositions for improving the viability of cryopreserved cells
WO2011019619A1 (en) * 2009-08-11 2011-02-17 Genentech, Inc. Production of proteins in glutamine-free cell culture media
CA2939165A1 (en) * 2009-09-15 2011-03-24 Cerulean Pharma Inc. A cdp-camptothecin conjugate, particle or composition and uses thereof
US8815860B2 (en) * 2009-09-24 2014-08-26 Emory University Methods for preventing oxidative stress injury of a tissue by a Folate-TEMPOL conjugate
US9488644B2 (en) * 2009-11-11 2016-11-08 The Trustees Of Columbia University In The City Of New York Assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease
FR2996413B1 (fr) * 2012-10-10 2014-12-05 Maco Pharma Sa Procede pour conserver le sang placentaire
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie

Also Published As

Publication number Publication date
RU2727643C2 (ru) 2020-07-22
CN108135154B (zh) 2022-12-23
WO2017042501A1 (fr) 2017-03-16
FR3040860A1 (fr) 2017-03-17
RU2017142903A (ru) 2019-06-10
CA2986267A1 (fr) 2017-03-16
HK1250604A1 (zh) 2019-01-11
US11589575B2 (en) 2023-02-28
US20180184643A1 (en) 2018-07-05
CN108135154A (zh) 2018-06-08
EP3346833B1 (fr) 2022-12-14
EP3346833A1 (fr) 2018-07-18
RU2017142903A3 (OSRAM) 2020-01-14

Similar Documents

Publication Publication Date Title
IL285359A (en) Anaerobic blood storage containers
EA201890926A1 (ru) ТРИАЗОЛОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
EP3589284A4 (en) USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS
IL252981A0 (en) 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis
UA122520C2 (uk) Кристалічна форма 2-[4-(4-хлорфенокси)-2-(трифторметил)феніл]-1-(1,2,4-триазол-1-іл)пропан-2-олу, агрохімічна композиція, застосування та спосіб боротьби зі шкідливими грибами
MX2018013983A (es) Inhibidores g12c de kras.
CL2018000070A1 (es) Modulares de diaciglicerol aciltransderasa 2 (dgta2)
EA201791084A1 (ru) Новые формы стандартизации и медицинские устройства для получения тромбоцитарно-обогащенной плазмы (prp) или фугата костного мозга (bmc) отдельно или в комбинации с гиалуроновой кислотой
IL249916A0 (en) Generation of a mesenchymal stromal cell bank from the pooled mononuclear cells of multiple bone marrow donors
EP3750821A4 (en) CONTAINER
PL3433232T3 (pl) Nowa sól addycyjna 1-(5-(2,4-difluorofenylo)-1-((3-fluorofenylo)sulfonylo)-4-metoksy-1H-pirol-3-ilo)-N-metylometanoaminy z kwasem
EA201490688A1 (ru) 2-тиопиримидиноны
EP4081070A4 (en) SHELF STORAGE SYSTEM
EP4299431A4 (en) VESSEL
EP3781212C0 (en) COAGULATION FACTOR XIII INHIBITORS
EP4177180A4 (en) CONTAINER
EP3575514C0 (en) Funeral structure for containing funerary objects
EP4411485A4 (en) CONTAINER
JP1738141S (ja) 検体保管用容器
IL279318A (en) Storage shelf
EP3781484A4 (en) MULTIFUNCTIONAL CRYOGENIC STORAGE VESSEL
EP4347418C0 (en) CONTAINER
FR3020271B1 (fr) Utilisation de cellules vegetales de bougainvillier pour l'encapsulation d'ingredients actifs
EP4101781A4 (en) Container
EA201792093A1 (ru) 2-тиопиримидиноны

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170317

PLFP Fee payment

Year of fee payment: 3

TQ Partial transmission of property

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR

Effective date: 20180116

Owner name: UNIVERSITE DE BORDEAUX, FR

Effective date: 20180116

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11